Binance Labs backs BIO Protocol in a push to decentralize scientific research funding via blockchain, advancing global biotech innovation.

WASHINGTON — If you missed the early fall push for flu and COVID-19 vaccines, it's not too late. Health officials say it's ...

Prelude has also collaborated with Pfizer Ignite to support its SMARCA2 degrader programs, benefiting from Pfizer’s extensive ...

Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and ...

Pfizer Inc. (NYSE:PFE) is a global biopharmaceutical company that develops and markets medicines and vaccines across areas ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

PHILADELPHIA — The same technology that saved millions of lives during the COVID-19 pandemic appears to hold promise against another scourge of infectious disease, according to new research from the ...

Pfizer (PFE, Financials) announced plans to invest $1 billion in China over the next five years to enhance research and ...

Viatris is poised for appreciation with new product launches and a stronger balance sheet. Read why VTRS stock is a buy due ...

On Thursday, Pfizer Inc (PFE) stock saw a modest uptick, ending the day at $27.46 which represents a slight increase of $0.10 or 0.37% from the prior close of $27.36. The stock opened at $27.53 and ...

BIO aims to use blockchain technology to change how early-stage scientific research is financed and commercialized.

More U.S. investors are launching companies stateside that license technology from China, even as Congress moves to crack down on some Chinese companies through the BIOSECURE Act. Read more.